Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 6/20 | 0.63 |
| ▸ | DRD3 | P35462 | 6/20 | 0.63 |
| ▸ | VCP | P55072 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | DRD1 | P21728 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD5 | P21918 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PRCP | P42785 | 1/20 | 0.40 |
| ▸ | EBP | Q15125 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7323009 | 0.81 | DRD3 (0.66) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL2603312 | 0.79 | KCNH2 (0.61) | DRD2DRD3KCNH2HRH3DRD1 | |
| SCHEMBL21323287 | 0.79 | DRD2 (0.63) | DRD2DRD3PARP1PARP2KCNH2 | |
| SCHEMBL17658922 | 0.79 | DRD2 (0.63) | DRD2DRD3PARP1PARP2KCNH2 | |
| SCHEMBL2603277 | 0.79 | DRD2 (0.63) | DRD2DRD3PARP1PARP2KCNH2 | |
| SCHEMBL24434619 | 0.78 | DRD2 (0.54) | DRD2DRD3KCNH2HRH3DRD1 | |
| SCHEMBL23102153 | 0.78 | DRD2 (0.63) | DRD2DRD3KCNH2 | |
| SCHEMBL7349109 | 0.77 | DRD3 (1.00) | DRD2DRD3DRD1DRD4DRD5 | |
| SCHEMBL11400486 | 0.77 | DRD3 (0.62) | DRD2DRD3 | |
| SCHEMBL22795471 | 0.77 | DRD2 (0.54) | DRD2DRD3PARP1PARP2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | ENODIA THERAPEUTICS SAS (FR) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153732-A1 | PROTEIN SECRETION INHIBITORS | SEC61B, SEC61A1, SEC61G | DRD2 4602/4885DRD3 4250/4885VCP 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.